Percutaneous Nephrolithotomy (PCNL)

3

Review clinical trials related to Percutaneous Nephrolithotomy (PCNL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Erector Spinae Plane Block for Percutaneous Nephrolithotomy

Percutaneous nephrolithotomy (PCNL) is an effective standard urological procedure for the fragmentation and removal of large renal calculi. Although PCNL is performed as a minimally invasive technique, dilation of the renal capsule and parenchymal tract, as well as peritubular distension caused by the nephrostomy tube, may result in severe postoperative pain. Various analgesic strategies have been described in the literature for postoperative pain management following PCNL. These include systemic opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and several regional analgesia techniques. However, due to their adverse effect profiles, opioids and NSAIDs are not ideal options, particularly in patients with renal dysfunction. Regional techniques that have been utilized include local infiltration, intercostal nerve blocks, paravertebral blocks, and epidural analgesia. The kidney is primarily innervated between the T10 and L1 segments, whereas the ureter receives innervation from T10 to L2. Based on this anatomical knowledge, unilateral regional blockade between T10 and L2 can provide adequate analgesia for PCNL procedures. Thoracic paravertebral block was previously a commonly preferred technique; however, it may be associated with complications such as intravascular injection, unintended epidural or intrathecal spread, and pneumothorax during its performance. In recent years, the number of reports describing the use of the erector spinae plane block (ESPB) as part of multimodal anesthesia for postoperative analgesia has increased. In ESPB, local anesthetic is injected into the interfascial plane between the transverse process of the vertebra and the erector spinae muscles, and has been reported to spread to multiple paravertebral spaces. ESPB is considered a peri-paravertebral block that can affect both visceral and somatic pain pathways. The aim of this study is to evaluate the effect of ultrasound-guided erector spinae plane block on intraoperative and postoperative opioid consumption, postoperative pain scores, and quality of recovery in patients undergoing percutaneous nephrolithotomy.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Fadime TosunUpdated: Mar 11, 2026
Eligibility criteria

Age ≥ 18 years. [+3]

Age < 18 years. [+6]

Status: Recruiting

Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy

This prospective, randomized controlled study evaluates the hemodynamic effects of prone and supine positions during percutaneous nephrolithotomy (PNL) for large kidney stones. Surgical position may influence intraoperative and postoperative hemodynamic stability. Prone positioning can increase intrathoracic pressure and reduce venous return, whereas supine positioning may provide greater hemodynamic stability. A total of 84 patients will be randomized to undergo PNL in prone or supine positions. Primary outcomes include changes in hemodynamic parameters during surgery. Results may guide surgical position selection, especially in patients with potential hemodynamic risk.

Participants needed: 84
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Gaziosmanpasa Research and Education HospitalUpdated: Aug 24, 2025Locations: 1
Eligibility criteria

ASA physical status I-III [+1]

Pregnancy [+7]

Status: Not yet recruiting

Erector Spinae Block vs Conventional Analgesia for Postoperative Analgesia in PCNL

50 adult patients scheduled for percutaneous nephrolithotomy in Sohag university hospitals will be devided in two groups one of them will receive Sonographic guided erector spinae plane block using 20 ml volume of bupivacaine 0.25 percent and the other will receive conventional analgesia of 0.1 mg/kg IV morphine

Participants needed: 50
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Sohag UniversityUpdated: Apr 18, 2025
Eligibility criteria

ASA 1 to ASA 2 18 to 60 years

patient refusal Significant neurological , psychiatric or neuromascular disease...